ORTEXORTEX News
Tracking APH? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AP
Earnings PreviewAPH

APH Options Lean Bullish as Earnings Loom

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 26 Jul 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Amphenol heads into its July 29 Q2 print with options traders notably less defensive than usual — a shift worth examining given the stock's recent wobble.

The clearest change since last week's article is in options positioning. The put/call ratio has pulled back to 0.76, almost a full standard deviation below its 20-day average of 0.82. That represents a meaningful drift toward calls relative to recent norms, and stands in contrast to the cautious tape: APH fell 3% on Friday to close at $152.67, leaving it down roughly 4% on the month. The borrow market offers no drama whatsoever — availability is effectively unlimited, borrowing costs run below 0.4%, and short interest has edged down 7.5% over the past month to just 1.3% of the float. There is no meaningful short-side pressure in the setup.

The analyst backdrop, covered in detail in last week's note, remains the dominant frame. Five firms raised targets in the days before that article; the consensus target at $189.39 still implies roughly 24% upside to Friday's close, a gap that has barely narrowed as the stock drifted lower. Bulls point to Amphenol's exposure to AI infrastructure buildout, EV adoption, and defense connectivity — segments where hyperscale capex and electrification trends act as structural tailwinds. The PE multiple has eased to around 29x from its recent highs, which bears will note is still elevated for a business where industrial production is softening, automotive supply chains remain constrained, and acquisition targets have become harder to find at sensible multiples.

One institutional footnote worth mentioning: Capital Research added roughly 24 million shares in the quarter ending June 30, making it one of the larger disclosed additions among the top holders. That's a meaningful conviction move from a long-only manager, and it runs directly against the modest insider selling — the CEO sold approximately $19 million of stock in early May. The net insider flow over 90 days is dominated by those sales, so insiders and at least one major institution are pointing in opposite directions heading in.

The July 29 print will test whether Amphenol's AI and defense exposure is already translating into the kind of revenue acceleration that justifies a $189 consensus target — or whether the industrial drag and automotive friction are enough to widen the gap between the Street's optimism and what the numbers actually show.

Stocks in this article

See the live data behind this article on ORTEX.

Open APH on ORTEX →

How this article was generated

Generated
26 Jul 2026, 04:03
Data as of
26 Jul 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.